Epic confirmed on Tuesday that its long-rumored AI scribe feature is a reality. The company said it’s working with Microsoft-owned Nuance—and with clinical documentation standout Abridge—to add the feature to its platform.

The company operates across six countries with plans to enter the U.S., offering its flagship BMVision Kidney, helping to detect malignant lesions in the organ. 

New research published in Lancet Digital Health details the improved cancer detection rates achieved when AI serves as a second reader. 

If not for off-limits data, AI might have a decent shot at curing cancer. 

Nurse leaders seeking AI acceptance from those they lead would do well to apply psychological insights along with technical tips.  

Experts involved in its development describe the model's capabilities as “a major milestone” in women’s health. 

Artificial intelligence tools in radiology require constant monitoring to ensure model performance remains consistent.

Heartflow has officially gone public after selling more than 19 million shares of common stock during an upsized IPO. The California medtech company, known for its AI-powered CCTA evaluations, is now being traded on Nasdaq under the symbol HTFL.